These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 6120459

  • 1. Sulfasalazine-induced exacerbation of ulcerative colitis.
    Schwartz AG, Targan SR, Saxon A, Weinstein WM.
    N Engl J Med; 1982 Feb 18; 306(7):409-12. PubMed ID: 6120459
    [No Abstract] [Full Text] [Related]

  • 2. [Salazosulfapyridine-induced exacerbation of ulcerative colitis].
    Dominick HC, Müller KM, Mensing E.
    Monatsschr Kinderheilkd; 1985 May 18; 133(5):304-6. PubMed ID: 2861562
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.
    Kam L, Cohen H, Dooley C, Rubin P, Orchard J.
    Am J Gastroenterol; 1996 Jul 18; 91(7):1338-42. PubMed ID: 8677990
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon.
    Frühmorgen P, Demling L.
    Hepatogastroenterology; 1980 Dec 18; 27(6):473-6. PubMed ID: 6110627
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
    Malchow H.
    Internist (Berl); 1987 Jan 18; 28(1):14-20. PubMed ID: 2883152
    [No Abstract] [Full Text] [Related]

  • 11. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission.
    Eliakim R, Wengrower D, Ligumsky M, Rachmilewitz D.
    Isr J Med Sci; 1990 Jan 18; 26(1):47-9. PubMed ID: 1968895
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM, Greenberg GR.
    Am J Gastroenterol; 1988 Jan 18; 83(1):15-9. PubMed ID: 2892391
    [Abstract] [Full Text] [Related]

  • 15. Refractory distal ulcerative colitis responsive to 5-aminosalicylate enemas.
    Barber GB, Lee DE, Antonioli DA, Peppercorn MA.
    Am J Gastroenterol; 1985 Aug 18; 80(8):612-4. PubMed ID: 2862789
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A comparison of serum concentrations of sulphasalazine and some of its metabolites after therapy by the oral or rectal route.
    Ashworth M, Arthur M, Turmer AD, Smith PR.
    Pharmatherapeutica; 1984 Aug 18; 3(8):551-5. PubMed ID: 6142465
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sulfasalazine and new analogues.
    Friedman G.
    Am J Gastroenterol; 1986 Feb 18; 81(2):141-4. PubMed ID: 2868653
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.